Literature DB >> 17159498

Evaluation of 5-fluorouracil applicability by the collagen gel droplet embedded drug sensitivity test with area under the curve analysis.

Takumi Ochiai1, Kazuhiko Nishimura, Hajime Noguchi, Tomoo Watanabe, Masayuki Kitajima, Nanami Konishi, Go Sato, Isao Nagaoka, Shunji Futagawa.   

Abstract

We have evaluated the 5-fluorouracil sensitivity of cancer cells from colorectal cancer patients using the collagen gel droplet embedded drug sensitivity test under multiple drug concentrations and contact durations. After converting drug concentration and contact time to the area under the curve (AUC) and plotting against the growth inhibition rate, the correlation between AUC and the growth inhibition rates was approximated to the logarithmic regression curve. In this study, to further validate the reliability of the regression curve, the growth inhibition rate was calculated from the regression curve and the actual growth inhibition rate was compared at AUC of 48 mug h/ml. No significant difference was observed in the growth inhibition rates between the two groups by paired t-test (P=0.590). A strong positive correlation was found between the two groups by regression analysis (y=0.7555x+10.514, R=0.8236). This result strongly suggests that in-vitro antitumor effect of 5-fluorouracil depends on the AUC in colorectal cancer and the AUC-inhibition rate curve is reliable. We can obtain the inhibition rate from AUC and vice versa using the AUC-inhibition rate curve. We can also calculate the individualized AUCIR50, AUC value that gives 50% growth inhibition, using the AUC-inhibition rate curve. This could be useful to establish individualized chemotherapy using the collagen gel droplet embedded drug sensitivity test.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17159498     DOI: 10.1097/01.cad.0000236314.58456.de

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  2 in total

1.  Leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan as individualized first-line therapy based on a drug sensitivity test.

Authors:  Takumi Ochiai; Kazuhiko Nishimura; Tomoo Watanabe; Masayuki Kitajima; Tadasuke Hashiguchi; Akinori Nakatani; Takashi Marusasa; Akira Muraki; Isao Nagaoka; Shunji Futagawa
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

2.  Identification of responders/non-responders to 5-fluorouracil based on individual 50% inhibitory area under the concentration curve of 5-fluorouracil obtained with collagen gel droplet-embedded culture-drug sensitivity test in colorectal cancer.

Authors:  Takumi Ochiai; Kazuhiko Nishimura; Tomoo Watanabe; Masayuki Kitajima; Akinori Nakatani; Takashi Marusasa; Tadasuke Hashiguchi; Takayuki Uchida; Naoki Sakuyama; Tsuyoshi Sato; Kennji Kishine; Shunji Futagawa; Isao Nagaoka
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.